Cargando…
Associations Between Cessation of Second-Line Therapies and Relapse Rates of Childhood Refractory Minimal-Change Nephrotic Syndrome: A Single-Center, Retrospective Chart Review
BACKGROUND: Most patients (≥85%) with minimal-change nephrotic syndrome (MCNS) respond to corticosteroid treatment. However, about 10% to 20% of patients with MCNS have steroid-resistant nephrotic syndrome and 25% to 43% of patients have steroid-dependent nephrotic syndrome or frequent-relapse stero...
Autores principales: | Jin, Jing, Li, Yufeng, Zhu, Yaju, Ni, Jiajia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092853/ https://www.ncbi.nlm.nih.gov/pubmed/35574245 http://dx.doi.org/10.1016/j.curtheres.2022.100671 |
Ejemplares similares
-
Experience with second line drugs in frequently relapsing and steroid dependent childhood nephrotic syndrome in a large Saudi center
por: Alsaran, Khalid, et al.
Publicado: (2017) -
Second-Line Immunosuppressive Treatment of Childhood Nephrotic Syndrome: A Single-Center Experience
por: Kim, J., et al.
Publicado: (2014) -
Urinary indices during relapse of childhood nephrotic syndrome
por: Iyengar, A. A., et al.
Publicado: (2011) -
Predictors of Relapse in Adult-Onset Nephrotic Minimal Change Disease
por: Lee, Hajeong, et al.
Publicado: (2016) -
High Albumin Clearance Predicts the Minimal Change Nephrotic Syndrome Relapse
por: Kuno, Hideaki, et al.
Publicado: (2023)